New results show promise in treatment of SOD1-ALS

lesturnerClinical Trials, Foundation Blog, Home Page, Research News

New results from the Phase 3 clinical trial of tofersen, a drug in development by Biogen, have shown promise in treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). According to the 12-month data, earlier initiation of treatment with …

NU-9 Update: Experimental drug repairs upper motor neurons in mouse model

lesturnerFoundation Blog, Home Page, Research News

As connecting fibers between motor neurons, axons help deliver vital messages between the brain and the spinal cord. For people living with ALS, deteriorating axons cause that connection to break, contributing to paralysis and death. Early research on NU-9, an …

March 2021 Events eNews

lesturnerFoundation eNews, Home Page

Last Call for Gourmet Dinner Delivery with our Hope Through Caring Gala The 2021 Virtual Hope Through Caring Gala is less than two weeks away on Saturday, March 20! Don’t miss out on a spectacular evening to create a world …

Drs. Jonathan Brent and Senda Ajroud-Driss converse in a hallway.

Faces of ALS: Working to Make True on a Wish

lesturnerAdvocacy, Faces of ALS, Home Page

When Jonathan Brent, MD, PhD, asks his ALS patients what their goals are, the answer is almost always the same: to find a cure for ALS. “What motivates me,” says Dr. Brent, “is how I can make true on that …